Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 21, 2020
Recombinetics has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.
read more
With its acquisition of IRISYS, Recro has transformed itself into a full-service CDMO with operations on both the East and West Coast of the U.S. capable of offering its now expanded global client base access to services spanning from pre-...
read more
Wednesday, September 08, 2021
Recro Pharma, Inc. a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic development, and BioCorRx, a developer and provider of advanced ...
read more
Wednesday, February 17, 2021
Recro Pharma has announced key appointments to its management team and board of directors.
read more
Recro Pharma, Inc. announced that it is changing its name to Societal CDMO, Inc. to reflect the corporate transformation that has taken place primarily as a result of its acquisition and successful integration of IriSys, Inc. into the organization.
read more
Monday, November 01, 2021
Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, announced the signing of a master supply and ...
read more
Wednesday, January 19, 2022
Recro Pharma, Inc. announced the appointment of Eduardo Uribe as the company’s head of quality for Recro San Diego. Mr. Uribe has more than 30 years of experience developing, implementing and managing quality systems within the biotechnology and ...
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as...
read more
Recro Pharma, Inc. announces the signing of a new development agreement with Astex Pharmaceuticals, Inc.
read more
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced that it has expanded the clinical ...
read more
Additional contract broadens and further strengthens customer product portfolio.
read more
Monday, November 05, 2018
Recro Gainesville has added a 24,000-square-foot facility near its existing 97,000-square-foot contract pharmaceutical development and manufacturing plant.
read more
Recro Gainesville has expanded its capabilities by adding a new tablet manufacturing suite and growing its development team.
read more
Recro Pharma announced its CDMO division, has amended its existing license and supply agreement with Teva Pharmaceutical to extend the agreement for six years, effective January 1, 2019.
read more
Thursday, February 24, 2022
Recro Pharma reported key progress in adding fill/finish and lyophilization capabilities to its broad suite of CDMO offerings. All construction and equipment installation related to this service expansion has been completed at the company’s San Diego...
read more